User acceptance of a computer-assisted anticoagulation control system.
作者信息
Vossepoel A M
出版信息
Med Inform (Lond). 1981 Apr-Jun;6(2):131-6. doi: 10.3109/14639238109003749.
PMID:7300504
Abstract
摘要
相似文献
1
User acceptance of a computer-assisted anticoagulation control system.用户对计算机辅助抗凝控制系统的接受度。
Med Inform (Lond). 1981 Apr-Jun;6(2):131-6. doi: 10.3109/14639238109003749.
2
[Anticoagulation with phenprocoumon in early childhood: dosage, complications, effectiveness].[幼儿期使用苯丙香豆素进行抗凝治疗：剂量、并发症、疗效]
Klin Padiatr. 1989 Jan-Feb;201(1):21-7. doi: 10.1055/s-2007-1025270.
3
[Change from heparin to phenprocoumon].[从肝素转换为苯丙香豆素]
Dtsch Med Wochenschr. 1978 Sep 8;103(36):1394.
4
[Tooth extraction in Marcumar-treated patients].[接受香豆素治疗患者的拔牙情况]
ZFA (Stuttgart). 1976 Sep 10;52(25):1293.
5
[Blood coagulation monitoring in oral anticoagulant therapy using chromogenic substances].
Med Lab (Stuttg). 1981;34(3):88-91.
6
Factors responsible for interindividual differences in the dose requirement of phenprocoumon.
Eur J Clin Pharmacol. 1987;33(1):49-54. doi: 10.1007/BF00610379.
7
[Coumarin therapy during antirheumatism therapy with sulindac].[舒林酸抗风湿治疗期间的香豆素疗法]
Z Rheumatol. 1980 Mar-Apr;39(3-4):102-8.
8
Plasma hypercoagulability after termination of oral anticoagulants.
Thromb Res. 1983 Mar 15;29(6):627-33. doi: 10.1016/0049-3848(83)90217-7.
9
Individualization of drug dosage during long-term treatment with phenprocoumon (Falithrom).苯丙香豆素（法利血栓）长期治疗期间的药物剂量个体化
Int J Clin Pharmacol Biopharm. 1978 Aug;16(8):372-6.
Zotero 插件